Sellas Life Sciences Group Inc (SLS)
Net Change in Cash
$113.05M
TTM · Period ending: · USD
SLS Net Change in Cash
Latest reported$113.05Mperiod ending
Latest reported$113.05Mperiod ending
SLS TTM Net Change in Cash ($1.76M → $113.05M)
TTM net change in cash
High-resolution chart · PNG
SLS net change in cash history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Net Change in Cash (USD) |
|---|---|
| 113,046,000 | |
| 78,700,000 | |
| 57,907,000 | |
| 23,289,000 | |
| 16,150,000 | |
| 9,982,000 | |
| 11,356,000 | |
| 17,062,000 | |
| -4,660,000 | |
| -5,487,000 | |
| -14,595,000 | |
| -17,379,000 | |
| -13,180,000 | |
| 9,650,000 | |
| -4,230,000 | |
| -4,933,000 | |
| -2,930,000 | |
| -13,781,000 | |
| -13,947,000 | |
| 18,078,000 | |
| 26,577,000 | |
| 21,287,000 | |
| 28,025,000 | |
| -931,000 | |
| -9,425,000 | |
| 4,156,000 | |
| 1,926,000 | |
| -848,000 | |
| 2,870,000 | |
| -9,396,000 | |
| -7,299,000 | |
| -13,263,000 | |
| -18,509,000 | |
| -25,985,000 | |
| -15,764,000 | |
| -11,600,000 | |
| -1,517,000 | |
| -7,069,000 | |
| -11,647,000 | |
| -10,298,000 | |
| -25,689,000 | |
| -18,151,000 | |
| 6,080,000 | |
| 10,165,000 | |
| 6,117,000 | |
| 433,000 | |
| -24,137,000 | |
| -26,749,000 | |
| 18,243,000 | |
| 34,946,000 | |
| 14,980,000 | |
| 35,973,000 | |
| 1,691,000 | |
| 8,780,000 | |
| 21,374,000 | |
| -270,000 | |
| 1,295,000 | |
| -2,414,000 | |
| 4,542,000 | |
| 12,857,000 | |
| 12,840,000 | |
| -3,739,000 | |
| 1,207,000 | |
| -6,152,000 | |
| 731,000 | |
| 7,682,000 | |
| -4,172,000 | |
| 5,324,000 | |
| -4,658,000 | |
| -2,685,000 | |
| 8,093,000 | |
| 1,310,000 | |
| -5,945,000 | |
| 9,854,000 | |
| 1,760,000 | |
| 2,351,000 |